Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled date : 2022 - 10 - 25 save search
Morphic Presents New Positive MORF-057 Phase 1 Data at American College of Gastroenterology Annual Meeting 2022
Published: 2022-10-25 (Crawled : 20:00) - globenewswire.com
MORF | $27.41 -0.36% 43K
|
Health Technology
|
| O: -0.04%
H: 5.26%
C: 3.81%
morf-057 meeting positive phase 1
Revelation Biosciences Inc. Announces Positive Results in Preclinical Model of Acute and Chronic Kidney Disease
Published: 2022-10-25 (Crawled : 16:00) - biospace.com/
REVB | $2.24 12K
|
|
| O: 28.83%
H: 55.86%
C: 27.76%
disease preclinical kidney positive results
Global Nutraceuticals Market Report 2022-2027: Growing Demand for Personalized Nutrition to have Positive Impact
Published: 2022-10-25 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 5.27%
H: 0.0%
C: -2.17%
HLF | $8.885 3.43% 330K
|
Distribution Services
|
| O: 0.24%
H: 6.9%
C: 6.42%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.57%
H: 1.16%
C: 0.94%
GIS 4 | $69.81 1.04% 700K
|
Consumer Non-Durables
|
| O: -0.26%
H: 1.46%
C: 1.14%
ADM | $62.66 1.52% 770K
|
Process Industries
|
| O: 1.06%
H: 1.58%
C: 1.01%
ABT | News | $107.24 1.87% 2M
|
Health Technology
|
| O: -0.22%
H: 0.85%
C: -0.12%
global nutrition report growing impact positive market
ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
GLAXF | $20.2 510
|
Health Technology
|
| O: 5.27%
H: 0.0%
C: -2.17%
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.59%
H: 1.21%
C: 0.71%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.57%
H: 1.16%
C: 0.94%
offering treatment antibody hiv potential positive
Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive Ichthyosis
Published: 2022-10-25 (Crawled : 13:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 2.67%
H: 1.3%
C: -3.51%
tmb-001 pharmaceuticals designation positive
Gritstone Presents Positive Results from Two Phase 1 CORAL Studies, Providing Further Proof-of-Concept for Self-amplifying mRNA (samRNA) in Infectious Diseases
Published: 2022-10-25 (Crawled : 11:00) - globenewswire.com
GRTS | $0.7477 0.54% 600K
|
Health Technology
|
| O: -1.33%
H: 11.88%
C: 9.87%
mrna positive phase 1
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.